Efficacy of ruxolitinib for HAVCR2 mutation-associated hemophagocytic lymphohistiocytosis and panniculitis manifestations in children.
Br J Haematol
; 202(1): 135-146, 2023 07.
Article
in En
| MEDLINE
| ID: mdl-37062931
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Panniculitis
/
Lymphohistiocytosis, Hemophagocytic
Type of study:
Risk_factors_studies
Limits:
Child
/
Child, preschool
/
Humans
/
Infant
Language:
En
Journal:
Br J Haematol
Year:
2023
Document type:
Article
Country of publication: